JP2005503339A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503339A5 JP2005503339A5 JP2002582924A JP2002582924A JP2005503339A5 JP 2005503339 A5 JP2005503339 A5 JP 2005503339A5 JP 2002582924 A JP2002582924 A JP 2002582924A JP 2002582924 A JP2002582924 A JP 2002582924A JP 2005503339 A5 JP2005503339 A5 JP 2005503339A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/832,752 US20030022811A1 (en) | 2001-04-11 | 2001-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| US11848602A | 2002-04-08 | 2002-04-08 | |
| PCT/US2002/011397 WO2002085351A1 (en) | 2001-04-11 | 2002-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005503339A JP2005503339A (ja) | 2005-02-03 |
| JP2005503339A5 true JP2005503339A5 (enrdf_load_stackoverflow) | 2008-11-20 |
Family
ID=26816420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002582924A Pending JP2005503339A (ja) | 2001-04-11 | 2002-04-11 | 前立腺患者における健康関連クオリティオブライフ及び病気進行までの健康関連クオリティ適応時間の有利な調整 |
Country Status (10)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| WO2004100991A1 (en) * | 2003-05-15 | 2004-11-25 | Universite Catholique De Louvain | Use of endothelin-1 antagonists for improving cancer therapy |
| GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
| EP2037912A2 (en) * | 2006-05-15 | 2009-03-25 | Encysive Pharmaceuticals, Inc. | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist |
| WO2009026517A2 (en) | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
| WO2023011596A1 (zh) * | 2021-08-05 | 2023-02-09 | 中国药科大学 | 酰胺类化合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006397A2 (en) * | 1997-08-04 | 1999-02-11 | Abbott Laboratories | Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
-
2002
- 2002-04-11 WO PCT/US2002/011397 patent/WO2002085351A1/en not_active Ceased
- 2002-04-11 CA CA002442591A patent/CA2442591A1/en not_active Abandoned
- 2002-04-11 MX MXPA03009277A patent/MXPA03009277A/es unknown
- 2002-04-11 JP JP2002582924A patent/JP2005503339A/ja active Pending
- 2002-04-11 BR BR0205970-3A patent/BR0205970A/pt not_active IP Right Cessation
- 2002-04-11 PE PE2002000305A patent/PE20021032A1/es not_active Application Discontinuation
- 2002-04-11 AR ARP020101335A patent/AR033465A1/es not_active Application Discontinuation
- 2002-04-11 EP EP02726727A patent/EP1379238A1/en not_active Ceased
- 2002-04-11 CN CNA028116720A patent/CN1514727A/zh active Pending
- 2002-04-11 IL IL15807102A patent/IL158071A0/xx unknown